As of Aug 18
| +0.60 / +1.07%|
The 2 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 70.50, with a high estimate of 71.00 and a low estimate of 70.00. The median estimate represents a +24.67% increase from the last price of 56.55.
The current consensus among 2 polled investment analysts is to Buy stock in USANA Health Sciences Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.